** Shares of Australia's Sonic Healthcare SHL.AX rise as
much as 6.4% to A$27.865
** Stock set for strongest trading session since Feb 2023
and hits its highest since late-Oct
** Analysts at Morningstar say Sonic shares are currently
undervalued as the firm is performing in line with market
expectations
** Shares are undervalued against our unchanged A$32 fair
value estimate, says brokerage
** Morningstar estimates co's margin to expand in the long
term on increased operating leverage from higher volumes
** Now forecasts Sonic's Australian pathology and imaging
revenue to grow at a 5% and 7% compound annual growth rate,
respectively, over its 10-year forecast period
** Stock has fallen 18.3% this year, as of last close
(Reporting by Namrata Verma in Bengaluru)
((namrata.verma@thomsonreuters.com))